Heavyweight! First ADC Drug For Refractory Ovarian Cancer Receives Accelerated FDA Approval
Svante Pbo, a Swedish scientist, won the Nobel Prize in Physiology or Medicine in 2022. He initiated paleogenomics to study human evolution
New Drug For IDH1 Mutation/Relapsed/Refractory Acute Myeloid Leukaemia With Good Complete Remission Rates And Manageable Toxicity
New Strategies For Cancer Vaccines: Transforming Cancer Cells So They Can Become Cancer-Fighters Is Not Far Away!
"New 'Breakthrough' Alzheimer's Drug Approved: Slows Brain Decline By 27%, But $26,500/Year Pricing Controversial
New Study Reveals Antibiotic Abuse For Sore Throats Pushes Up The Third Leading Cause Of Death Worldwide
